News That Matters

Tag: and FierceBiotech

Synchron 40m: Khosla Ventures, Spark, and FierceBiotech
Updates

Synchron 40m: Khosla Ventures, Spark, and FierceBiotech

Synchron 40m is an initiative between venture capital firms Khosla Ventures, Spark, and FierceBiotech. The mission of the initiative is to provide up to $40 million in funding to early-stage life sciences companies and to accelerate the development of innovative treatments and cures. What Is Synchron 40m? Synchron 40m is a strategic partnership between venture capital firms Khosla Ventures, Spark, and FierceBiotech. It is focused on providing up to $40 million in funding to early-stage life sciences companies developing treatments and cures. The initiative is designed to bridge the gap between basic research and commercialization, as well as to help accelerate the development and delivery of innovative therapies to patients. Who Is Involved in Synchron 40m? The three venture capital fi...